12:00 AM
 | 
Jun 06, 2011
 |  BC Week In Review  |  Company News  |  Deals

Aegera, Pharmascience deal

Generics company Pharmascience acquired cancer company Aegera. Pharmascience said the acquisition will diversify its R&D activities. Aegera's pipeline include AEG35156, a second-generation antisense...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >